Latest news with #IndocoRemediesLtd
Business Upturn
4 days ago
- Business
- Business Upturn
Why are Indoco Remedies shares up 2% today? Explained
By Aditya Bhagchandani Published on August 13, 2025, 10:05 IST Indoco Remedies Ltd shares climbed over 2% to ₹299.30 in morning trade on Tuesday after the company announced it has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Rivaroxaban tablets, a generic version of Bayer's blockbuster anticoagulant Xarelto. The approval covers multiple dosage strengths — 2.5 mg, 10 mg, 15 mg, and 20 mg — positioning Indoco to tap into the lucrative US market for blood thinners, which has significant demand due to rising cardiovascular cases. Industry data shows Rivaroxaban sales in the US crossed $2 billion in recent years. Indoco said the launch will be executed through its marketing partner in the US, adding that this development strengthens its complex generics portfolio and enhances its revenue visibility in the American market. The stock's rally reflects investor optimism about the earnings potential from this launch, given that US generics typically offer higher margins than domestic formulations. Disclaimer: This article is for informational purposes only and does not constitute financial advice. Investing in equities involves risks. Please consult a certified financial advisor before making any investment decisions. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Standard
23-05-2025
- Business
- Business Standard
Windlas Biotech Ltd Slips 4.88%, BSE Healthcare index Shed 1.03%
Windlas Biotech Ltd has lost 9.89% over last one month compared to 1.44% fall in BSE Healthcare index and 1.1% rise in the SENSEX Windlas Biotech Ltd fell 4.88% today to trade at Rs 923. The BSE Healthcare index is down 1.03% to quote at 42080.34. The index is down 1.44 % over last one month. Among the other constituents of the index, Sun Pharmaceutical Industries Ltd decreased 4.08% and Indoco Remedies Ltd lost 3.58% on the day. The BSE Healthcare index went up 18.11 % over last one year compared to the 7.4% surge in benchmark SENSEX. Windlas Biotech Ltd has lost 9.89% over last one month compared to 1.44% fall in BSE Healthcare index and 1.1% rise in the SENSEX. On the BSE, 1506 shares were traded in the counter so far compared with average daily volumes of 5266 shares in the past one month. The stock hit a record high of Rs 1197 on 06 Nov 2024. The stock hit a 52-week low of Rs 552.85 on 04 Jun 2024.
